FDA-TRACK Releases FY 2021 and FY 2020 Data from PDUFA, BsUFA, ADUFA and AGDUFA - Drug Information Update

If your email program has trouble displaying this email, view it as a web page. FDA-TRACK Releases FY 2021 and FY 2020 Data from PDUFA, BsUFA, ADUFA and AGDUFA FDA-TRACK is releasing the latest annual User Fee Program data for animal and human drug and biosimilar products. Final review performance results for FY 2020 and preliminary performance results for FY 2021 are now available. The FDA utilizes the User Fee Programs to assess and collect fees to fulfill its mission of protecting the public health and accelerating innovation in the industry. The User Fee performance dashboards provide a concise, interactive, and visual presentation of the data in the legislatively-mandated Performance Reports to Congress. For more information about FDA-TRACK and what other centers across FDA are tracking, please visit our What's New page and the FDA-TRACK home page. Learn More This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA